DUBLIN, March 23, 2022 /PRNewswire/ — The “Pneumococcus Testing Market Research Report by Method, by Technology, by Product Type, by End User, by Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to from ResearchAndMarkets.com offer.

Research and Markets Logo

The global pneumococcal testing market size has been estimated at $1,293.67 million in 2020, is expected to reach $1,403.17 million in 2021, and is expected to grow at a CAGR of 8.83% to reach $2,339.19 million by 2027.

Market statistics:
The report provides market size analysis and forecasts for five major currencies – USD, EUR GBP, JPY and AUD. It helps organizational leaders make better decisions when currency data is readily available. In this report, the years 2018 and 2019 are considered as historical years, 2020 as the base year, 2021 as the estimated year and the years from 2022 to 2027 as the forecast period.

Segmentation and market coverage:
This research report categorizes Pneumococcal Testing to forecast revenue and analyze trends in each of the following submarkets:

  • Based on the method, the market has been studied through immunodiagnostics, molecular diagnostics, and point-of-care testing.

  • On the basis of technology, the market has been studied through Enzyme Immunoassay, Immunofluorescence, Immunohistochemistry, Nucleic Acid Sequence Based Amplification, Polymerase Chain Reaction, and Western Testing Blot.

  • On the basis of product type, the market has been studied through analyzers and consumables.

  • On the basis of end user, the market has been studied in Ambulatory Surgical Centers and Hospitals & Clinics.

  • Based on region, the market has been studied across the Americas, Asia Pacificand Europe, Middle East & Africa. The Americas are studied in more detail through Argentina, Brazil, Canada, Mexicoand United States. United States is explored in more detail through California, Florida, Illinois, new York, Ohio, Pennsylvaniaand Texas. the Asia Pacific is explored in more detail through Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwanand Thailand. Europe, Middle East & Africa is explored in more detail through France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emiratesand UK.

Competitive Strategy Window:
The strategic competitive window analyzes the competitive landscape in terms of markets, applications and geographies to help the vendor define an alignment or match between its capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for vendors to adopt successive strategies of merger and acquisition, geographic expansion, research and development, and new product introduction strategies to execute further business expansion and growth. during a forecast period.

FPNV positioning matrix:
The FPNV Positioning Matrix rates and categorizes vendors in the Pneumococcal Testing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Ratio price-performance, ease-of-use, product features, and customer support) that helps businesses make better decisions and better understand the competitive landscape.

Market share analysis:
The market share analysis offers the analysis of the vendors considering their contribution to the overall market. It gives the idea of ​​its revenue generation in the overall market compared to other providers in the space. It provides information on the performance of vendors in terms of revenue generation and customer base compared to others. Knowing the market share gives an idea of ​​the size and competitiveness of suppliers for the reference year. It reveals the characteristics of the market in terms of accumulation, fragmentation, dominance and merger.

The report provides information about the following pointers:
1. Market Penetration: Provides comprehensive information about the market offered by major players
2. Market Development: Provides detailed information on lucrative emerging markets and analyzes penetration in mature market segments
3. Market Diversification: Provides detailed information on new product launches, untapped geographies, recent developments and investments
4. Competitive Assessment and Intelligence: Provides a comprehensive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of key players
5. Product Development and Innovation: Provides smart insights into future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the global pneumococcal testing market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pneumococcal Testing Market during the forecast period?
3. What are the products/segments/applications/areas to invest in during the forecast period in the Global Pneumococcal Testing Market?
4. What is the competitive strategic window for opportunities in the Global Pneumococcal Testing Market?
5. What are the technological trends and regulatory frameworks in the global pneumococcal screening market?
6. What is the market share of the major vendors in the global pneumococcal testing market?
7. What modes and strategic moves are considered suitable for entering the Global Pneumococcal Disease Testing Market?

Main topics covered:

1. Preface

2. Research methodology

3. Executive Summary

4. Market Overview

5. Market Overview
5.1. Market dynamics
5.1.1. Drivers
5.1.1.1. Increased uptake of pneumococcal screening with improved early diagnosis and treatment
5.1.1.2. Increase in the prevalence of pneumococcal disease
5.1.1.3. Ongoing clinical trials for the development of vaccines and drug molecules
5.1.2. Constraints
5.1.2.1. High cost associated with the development of pneumococcal screening methods
5.1.3. Opportunities
5.1.3.1. Growing Popularity of POC Testing
5.1.3.2. Increase R&D investments and advances in testing technologies for in vitro diagnostics (IVD)
5.1.4. Challenges
5.1.4.1. Shortage of professionals
5.2. Cumulative impact of COVID-19

6. Pneumococcal Testing Market, By Method
6.1. introduction
6.2. Immunodiagnostics
6.3. Molecular diagnostics
6.4. Point-of-care testing

7. Pneumococcal Testing Market, By Technology
7.1. introduction
7.2. Enzyme immunoassay
7.3. Immunofluorescence
7.4. Immunohistochemistry
7.5. Amplification based on nucleic acid sequence
7.6. Polymerase chain reaction
7.7. Western Blot test

8. Pneumococcal Testing Market, By Product Type
8.1. introduction
8.2. Analyzers
8.3. Consumables

9. Pneumococcal Testing Market, By End User
9.1. introduction
9.2. Ambulatory surgery centers
9.3. Hospitals and Clinics

10. Americas Pneumococcal Testing Market
10.1. introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Pneumococcal Testing Market
11.1. introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand

12. Europe, Middle East & Africa Pneumococcal Testing Market
12.1. introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. UK

13. Competitive Landscape
13.1. FPNV positioning matrix
13.1.1. Quadrants
13.1.2. Business strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market share analysis, by key player
13.4. Competitive scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, collaboration and partnership
13.4.3. Launching and improving new products
13.4.4. Investment & Financing
13.4.5. Reward, recognition and expansion

14. Company Usability Profiles
14.1. Abbott Laboratories
14.2. ACON LABORATORIES INC.
14.3. Agilent Technologies, Inc.
14.4. BECKMAN COULTERINC.
14.5. Becton, Dickinson and Company
14.6. Bio-Rad Laboratories, Inc.
14.7. bioMérieux SA
14.8. Cepheid Inc.
14.9. F-Hoffmann la Roche Ltd.
14.10. Hologic, Inc.
14.11. Karger S.A.
14.12. Merck KGaA
14.13. MERIDIAN BIOSCIENCE, INC.
14.14. Novartis AG
14.15. Pfizer Inc.
14.16. Portea Medical
14.17. Qiagen AG
14.18. Quest Diagnostics Incorporated
14.19. Rite Aid Corp.
2:20 p.m. Syngene International Ltd
14.21. Thermo Fisher Scientific Inc.
14.22. Trinity Biotech PLC

15. Appendix

For more information on this report, visit https://www.researchandmarkets.com/r/gs72h1

Media Contact:

Research and Markets
Laura Woodsenior
[email protected]

For EST office hours, call +1-917-300-0470
For USA/CAN call toll free +1-800-526-8630
For GMT office hours call +353-1-416-8900

US Fax: 646-607-1907
Fax (outside the US): +353-1-481-1716

Quote

Quote

Show original content:https://www.prnewswire.com/news-releases/global-pneumococcal-testing-market-research-report-to-2027—by-method-technology-product-type-end-user-and-region- 301508904.html

SOURCE Research and Markets

Previous

Record performances set the tone for Westlake

Next

Webcor and Reaume Richardson Form Strategic Alliance to Expand General Contracting Services in Southern California

Check Also